GEMZAR

This brand name is authorized in Brazil, Estonia, France, Hong Kong, Japan, Lithuania, Mexico, Singapore, Tunisia, United States, South Africa

Active ingredients

The drug GEMZAR contains one active pharmaceutical ingredient (API):

1 Gemcitabine UNII U347PV74IL - GEMCITABINE HYDROCHLORIDE

Gemcitabine (dFdC), which is a pyrimidine antimetabolite, is metabolised intracellularly by nucleoside kinase to the active diphosphate (dFdCDP) and triphosphate (dFdCTP) nucleosides. The cytotoxic effect of gemcitabine is due to inhibition of DNA synthesis by two mechanisms of action by dFdCDP and dFdCTP. Read about Gemcitabine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01BC05	Gemcitabine	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01B Antimetabolites → L01BC Pyrimidine analogues
Discover more medicines within L01BC05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 507601301152317, 507601302159315
Country: EE	Ravimiamet	Identifier(s): 1027550, 1027561
Country: FR	Base de données publique des médicaments	Identifier(s): 61928914, 67491777
Country: HK	Department of Health Drug Office	Identifier(s): 41786, 41787
Country: JP	医薬品医療機器総合機構	Identifier(s): 4224403D1030, 4224403D2037
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1003036, 1003037
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 079M97
Country: SG	Health Sciences Authority	Identifier(s): 09416P, 13229P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 5513041H, 5513042H
Country: US	FDA, National Drug Code	Identifier(s): 0002-7501, 0002-7502
Country: ZA	Health Products Regulatory Authority	Identifier(s): 29/26/306, 29/26/307